The acquisition will add approximately 300 products including projects in development as well as commercial and manufacturing capabilities in the US for Aurobindo.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2Q9T1Ui
via IFTTT
Aurobindo Pharma acquires dermatology business from Sandoz in a $0.9bn cash deal
The acquisition will add approximately 300 products including projects in development as well as commercial and manufacturing capabilities in the US for Aurobindo.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2Q9T1Ui
via IFTTT
0 comments:
Post a Comment